Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection

Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection

US Patent 6472373 · Granted Oct 29, 2002

Estimated economic value: $74,317,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ribavirin-pegylated interferon alfa induction HCV combination therapy2004
Combination therapy for chronic hepatitis C infection2002
Combination therapy for chronic hepatitis c infection2001
Combination therapy for eradicating detectable HCV-RNA in patients having chroni2001